低侵襲手術（MIS）機器の世界市場：洞察、競合情勢、市場予測：2030年

世界の低侵襲手術（MIS）機器の市場規模は、2023年に288億7,325万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に7.38％のCAGRで拡大し、2030年には424億9,900万米ドルに達すると予測されています。MIS機器市場は、2022年にがん関連死者数およびがん罹患率で最多を占めた肺がんなど、さまざまながんの有病率の上昇や、心血管疾患、神経変性疾患などのその他の適応症などの要因によって、前向きな市場成長が見られます。さらに、年齢がさまざまな適応症の開発に重要な役割を果たす高齢化人口の増加などの要因の存在も、MIS機器市場の成長を促進する要因の1つです。さらに、手術ロボットの開発など、製品開発における技術的進歩は、新製品が規制当局の承認を得て市場に参入していることから、MIS機器市場をさらに牽引しています。

MIS機器市場を牽引する重要な側面の1つは、がん罹患率の急増に起因しています。国際がん研究機関が実施した調査「GLOBOCAN 2022」によると、2020年には世界で1,930万人の新規がん患者（非黒色腫皮膚がんを除く1,810万人）と約1,000万人のがん死亡が報告されると推定されています。また、上記の情報源によれば、2020年には肺がんが最も多く（140万人）、次いで前立腺がん（14.1％）、大腸がん（10.6％）、胃がん（7.1％）、肝臓がん（6.3％）と続きます。がんは衰弱させる病気であるため、がん細胞を治療するためには大規模な治療が必要となります。手術はしばしば推奨される治療法であり、単切開腹腔鏡手術、内視鏡下鼻内手術、最小切開甲状腺切除術などの低侵襲手術は、低侵襲で手術を行うために特別に考案された様々な装置を使用する、がんの治療に採用されている低侵襲手術アプローチの一部です。このように、様々なタイプのMIS装置に対するニーズが高まっているのは、治療アプローチの一つとして外科的介入を必要とするがんの発生率が増加していることに起因しています。したがって、前述のすべての要因がMIS機器に対する需要の拡大に寄与し、最終的に世界のMIS機器市場の成長を後押しすると予測されます。

当レポートでは、世界の低侵襲手術（MIS）機器市場について調査し、市場の概要とともに、機器タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 低侵襲手術（MIS）機器市場レポートのイントロダクション

第2章 低侵襲手術（MIS）機器市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本
• 中国

第4章 低侵襲手術（MIS）機器市場の主な要因分析

• 低侵襲手術（MIS）機器市場の促進要因
• 低侵襲手術（MIS）機器市場の抑制要因と課題
• 低侵襲手術（MIS）機器市場の機会

第5章 低侵襲手術（MIS）機器市場におけるポーターのファイブフォース分析

第6章 低侵襲手術（MIS）機器市場におけるCOVID-19の影響分析

第7章 低侵襲手術（MIS）機器市場の概要

• 機器タイプ別
• 用途別
• エンドユーザー別
• 地域別

第8章 低侵襲手術（MIS）機器市場の世界企業シェア分析-主要3～5社

第9章 低侵襲手術（MIS）機器市場の企業と製品プロファイル

• Abbott
• Olympus
• Intuitive Surgical Inc
• Stryker
• JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES
• Medtronic
• Boston Scientific Corporation
• CONMED Corporation
• KARL STORZ GmbH
• CooperSurgical Inc
• Cook
• AngioDynamics
• FUJIFILM Corporation
• Symmetry Surgical Inc
• B. Braun Melsungen AG
• BD
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd
• Zimmer Biomet
• Richard Wolf GmbH
• Microport Scientific Corporation

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on MIS Devices Market
• Table 3: MIS Devices Market in Global (2021-2030)
• Table 4: MIS Devices Market in Global by Device Type (2021-2030)
• Table 5: MIS Devices Market in Global by Application (2021-2030)
• Table 6: MIS Devices Market in Global by End User (2021-2030)
• Table 7: MIS Devices Market in Global by Geography (2021-2030)
• Table 8: MIS Devices Market in North America (2021-2030)
• Table 9: MIS Devices Market in North America by Country (2021-2030)
• Table 10: MIS Devices Market in the US (2021-2030)
• Table 11: MIS Devices Market in Canada (2021-2030)
• Table 12: MIS Devices Market in Mexico (2021-2030)
• Table 13: MIS Devices Market in Europe (2021-2030)
• Table 14: MIS Devices Market in Europe by Country (2021-2030)
• Table 15: MIS Devices Market in France (2021-2030)
• Table 16: MIS Devices Market in Germany (2021-2030)
• Table 17: MIS Devices Market in the United Kingdom (2021-2030)
• Table 18: MIS Devices Market in Italy (2021-2030)
• Table 19: MIS Devices Market in Spain (2021-2030)
• Table 20: MIS Devices Market in Russia (2021-2030)
• Table 21: MIS Devices Market in Rest of Europe (2021-2030)
• Table 22: MIS Devices Market in APAC (2021-2030)
• Table 23: MIS Devices Market in APAC by Country (2021-2030)
• Table 24: MIS Devices Market in China (2021-2030)
• Table 25: MIS Devices Market in Japan (2021-2030)
• Table 26: MIS Devices Market in India (2021-2030)
• Table 27: MIS Devices Market in Australia (2021-2030)
• Table 28: MIS Devices Market in South Korea (2021-2030)
• Table 29: MIS Devices Market in Rest of APAC (2021-2030)
• Table 30: MIS Devices Market in Rest of World (2021-2030)
• Table 31: MIS Devices Market in RoW by Region (2021-2030)
• Table 32: MIS Devices Market in Middle East (2021-2030)
• Table 33: MIS Devices Market in Africa (2021-2030)
• Table 34: MIS Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on MIS Devices Market
• Figure 3: MIS Devices Market in Global (2021-2030)
• Figure 4: MIS Devices Market in Global by Device Type (2021-2030)
• Figure 5: MIS Devices Market in Global by Application (2021-2030)
• Figure 6: MIS Devices Market in Global by End User (2021-2030)
• Figure 7: MIS Devices Market in Global by Geography (2021-2030)
• Figure 8: MIS Devices Market in North America (2021-2030)
• Figure 9: MIS Devices Market in North America by Country (2021-2030)
• Figure 10: MIS Devices Market in the US (2021-2030)
• Figure 11: MIS Devices Market in Canada (2021-2030)
• Figure 12: MIS Devices Market in Mexico (2021-2030)
• Figure 13: MIS Devices Market in Europe (2021-2030)
• Figure 14: MIS Devices Market in Europe by Country (2021-2030)
• Figure 15: MIS Devices Market in France (2021-2030)
• Figure 16: MIS Devices Market in Germany (2021-2030)
• Figure 17: MIS Devices Market in the United Kingdom (2021-2030)
• Figure 18: MIS Devices Market in Italy (2021-2030)
• Figure 19: MIS Devices Market in Spain (2021-2030)
• Figure 20: MIS Devices Market in Russia (2021-2030)
• Figure 21: MIS Devices Market in Rest of Europe (2021-2030)
• Figure 22: MIS Devices Market in APAC (2021-2030)
• Figure 23: MIS Devices Market in APAC by Country (2021-2030)
• Figure 24: MIS Devices Market in China (2021-2030)
• Figure 25: MIS Devices Market in Japan (2021-2030)
• Figure 26: MIS Devices Market in India (2021-2030)
• Figure 27: MIS Devices Market in Australia (2021-2030)
• Figure 28: MIS Devices Market in South Korea (2021-2030)
• Figure 29: MIS Devices Market in Rest of APAC (2021-2030)
• Figure 30: MIS Devices Market in Rest of World (2021-2030)
• Figure 31: MIS Devices Market in RoW by Region (2021-2030)
• Figure 32: MIS Devices Market in Middle East (2021-2030)
• Figure 33: MIS Devices Market in Africa (2021-2030)
• Figure 34: MIS Devices Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Minimally Invasive Surgical (MIS) Devices Market By Device Type (Electrosurgical Devices, Endoscopes [Laparoscopes, Neuroendoscopy Systems, And Others], Inflation Devices, Handheld Instruments, Surgical Robotic Systems, And Others), By Application (Cosmetic, Orthopedic, Neurological, Gynecological,Cardiovascular, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is estimated to grow at a healthy CAGR forecast till 2030 due to rising prevalence of various cancers such as lung & breast cancers, and growing technological advancements resulting in the development of surgical robotic systems

Global MIS devices market was valued at USD 28,873.25 million in 2023, growing at a CAGR of 7.38% during the forecast period from 2024 to 2030, in order to reach USD 42,499 million by 2030. The MIS devices market is witnessing a positive market growth owing to the factors such as rising prevalence of various cancers such as lung cancer which accounted for the highest number of cancer-related deaths and highest cancer incidence in 2022, and other indications such as cardiovascular diseases, and neurodegenerative diseases among others. Furthermore, the presence of factors such as growth in aging population wherein age plays a key role in the development of various indications is another factor driving the growth of the MIS devices market. Moreover, the technological advancements in product development such as the development of surgical robots is further driving the MIS devices market as new products are gaining regulatory approvals and are entering the market.

Minimally Invasive Surgical (MIS) Devices Market Dynamics:

One of the key aspects driving the MIS devices market can be attributed to the surge in cancer incidence. The GLOBOCAN 2022, study conducted by the International Agency for Research on Cancer mentioned that in 2020, an estimated number of 19.3 million new cancer cases (18.1 million excluding non-melanoma skin cancer) and approximately 10.0 million cancer deaths were reported globally. The source mentioned above also stated that in 2020, lung cancer was the main cause accounting for the highest number (1.4 million) of cases followed by prostate (14.1%), colorectum (10.6%), stomach (7.1%), and liver (6.3%) cancers. Cancer, being a debilitating disease, requires extensive treatment in order to treat cancerous cells. Surgery is often a recommended mode of treatment wherein minimally invasive surgery such as single incision laparoscopic surgery, endoscopic endonasal surgery, and minimal-incision thyroidectomy are some of the minimally invasive surgical approaches that are employed in the treatment of cancers which make use of various devices specifically devised to conduct the procedure in a minimally invasive way. Thus, the growing need for MIS devices of various types can be attributed to the increasing cancer incidence that may require surgical intervention as one of the treatment approaches. Therefore, all the aforementioned factors are projected to contribute to the growing demand for MIS devices, ultimately boosting the growth of the global MIS devices market.

Additionally, MIS approaches such as surgical robotic systems are gaining popularity owing to their precision and minimal invasion of the surrounding anatomy. Furthermore, surgical robotic systems are being preferred by surgeons for conducting numerous surgical procedures due to aided benefits of precision and accuracy and better chances of reproducing positive surgical outcomes which further helps in faster recovery for patients. In general, the advantages associated with minimally invasive surgery such as fewer incisions resulting in less trauma to patients, faster healing time, significantly less hospitalization time, among others have made MIS approaches a popular option among surgeons and patients. Therefore, the MIS devices market is slated to register remarkable growth during the forecast period (2024-2030) owing to the factors mentioned above.

However, equipment used in MIS surgery being expensive as well as limited availability of skilled surgeons may prove to be challenging factors for MIS devices market growth.

The MIS devices market was negatively impacted by the implementation of measures to curb the spread of the COVID-19 infection. In order to cater to the exigency created by the COVID-19 pandemic, all other medical specialties witnessed a reduction in patient load. For instance, according to Cancer Research UK (2023), in the UK alone, urgent lung cancer referrals fell up to 75% during the first lockdown. This did not correlate to the decrease in cases, but that fewer people sought and obtained the diagnosis they urgently needed. Unfortunately, these trends were prominent across countries around the globe. With the suspension of a large number of elective procedures, numerous MIS surgeries were also postponed during the COVID-19 pandemic. Nevertheless, the market for MIS devices is on a period of recovery owing to devising of strategies to resume healthcare services across the globe thereby presenting a positive future outlook for MIS devices market during the forecast period from 2024-2030.

Minimally Invasive Surgical (MIS) Devices Market Segment Analysis:

MIS Devices Market by Device Type (Electrosurgical Devices, Endoscopes [Laparoscopes, Neuroendoscopy Systems, and Others], Inflation Devices, Handheld Instruments, Surgical Robotic Systems, and Others), by Application (Cosmetic, Orthopedic, Neurological, Gynecological, Cardiovascular, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of the MIS devices market, the surgical robotic systems are estimated to account for the significant revenue share in the year 2023. This can be attributed to the advantages offered by the surgical robotic systems in carrying out minimally invasive surgery. Surgical robots offer accuracy, stability, integration with modern imaging technology, greater range of motion, telesurgery, in addition to multiple other benefits exclusive to individual surgical specialties. These systems further help in overcoming challenges such as limited line of sight in endoscopy systems. These systems include ZEUS, AESOP, da Vinci systems that offer surgeons technologically advanced hand skills and visions. Considering the advantages associated with these systems, there has been an extensive focus on new product development and market approvals. For instance, in November 2022, Brain Navi Biotechnology, a Taiwan-based company received the CE (Conformite Europeenne) Mark for their NaoTrac, a robotic-assisted surgical robot.

Thus, owing to the factors stated above, this device type category is expected to witness a considerable growth eventually contributing the overall growth of the global MIS devices market during the forecast period.

North America is expected to dominate the overall Minimally Invasive Surgery (MIS) Devices Market:

Among all the regions, North America is estimated to account for the dominant share in the MIS devices market. Owing to significance of key growth factors such as growing prevalence of various cancers, increasing prevalence of degenerative bone disorders, and rising government initiatives regarding disease treatment awareness, the North America MIS devices market is expected to register positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and high awareness also helped the market growth in this region.

One of the key supporting factors for the growth of the North America MIS devices market is the increasing incidence of traumatic brain injury (TBI) as well as cancers in the United States. According to the data cited by the Centers for Disease Control and Prevention (CDC) 2022, in 2020, near about 64,362 TBI-related deaths and 223,135 TBI-related hospitalizations reported in 2019. In addition to the fact stated above, as per the figures mentioned by the American Cancer Society, in 2022, it was estimated that 1.9 million new cancer cases would have been diagnosed in the United States. Further, the data provided by the Centers for Disease Control and Prevention (2023), in 2018, 1,708,921 new cases of cancers were reported in the United States. For instance, the American Cancer Society estimates that in 2022, approximately 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the United States. TBIs are more commonly treated with minimally invasive approaches such as neuroendoscopy among others. Therefore, the increasing incidence of cancers such as breast cancer along with other cancer types as well as the incidence of traumatic brain injury in the country is expected to further drive the demand for MIS devices thereby contributing in the growth of the United States MIS devices market along with the overall growth of the North America MIS devices market.

Therefore, the presence of large patient pool, and extensive insurance coverage also motivates patients to opt for surgical interventions in the country which further is contributing in the demand for minimally invasive surgical devices such as robot-assisted surgical systems. For instance, a South Korea-based company, Koh Young Technology Inc is planning to launch a neurosurgical robotics system in the US market by 2022 after it receives the approval from the US Food and Drug Administration. Thus, all the factors mentioned above collectively contribute in the local demand for products ultimately driving the United States MIS devices market in the forecast period.

Minimally Invasive Surgical (MIS) Devices Market Key Players:

Some of the key market players operating in the MIS devices market include Abbott, Olympus, Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, Boston Scientific Corporation, CONMED Corporation, KARL STORZ GmbH, CooperSurgical, Inc., Cook, AngioDynamics, FUJIFILM Corporation, Symmetry Surgical Inc, B. Braun Melsungen AG, BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Zimmer Biomet, Richard Wolf GmbH, Microport Scientific Corporation others.

Recent Developmental Activities in Minimally Invasive Surgical (MIS) Devices Market:

In November, 2022, Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot) recently attended the 28th National Seminar for Laparoscopic Surgery Demonstration, to launch their DFVision® 3D Electronic Laparoscope (DFVision®).

In October 2022, Medtronic received the CE (Conformite Europeenne) Mark for their Hugo(TM) robotic-assisted surgery (RAS) system thereby enabling Medtronic to access European market for this device. The device received the approval for gynecologic and urological procedure.

In May 2019, Olympus launched the ESG- 150 Electrosurgery Generator (ESG-150) after receiving product approval from the US Food and Drug Administration.

Key Takeaways from the Minimally Invasive Surgical (MIS) Devices Market Report Study

• Market size analysis for current MIS devices market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the MIS devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global MIS devices market.
• Various opportunities available for the other competitors in the MIS devices market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current MIS devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for MIS devices market growth in the coming future?

Target Audience who can be benefited from this Minimally Invasive Surgical (MIS) Devices Market Report Study

• MIS devices products providers
• Research organizations and consulting companies
• MIS devices -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in MIS devices
• Various end-users who want to know more about the MIS devices market and latest technological developments in the MIS devices market.

Frequently Asked Questions for Minimally Invasive Surgical (MIS) Devices Market:

1. What is MIS Devices?

Minimally invasive surgical (MIS) devices are surgical devices that are designed to be compatible with devices used in minimally invasive surgery.

2. What is the global market for MIS Devices?

Global MIS devices market was valued at USD 28,873.25 million in 2023, growing at a CAGR of 7.38% during the forecast period from 2024 to 2030, in order to reach USD 42,499 million by 2030.

3. What are the drivers for Global MIS Devices Market?

The MIS devices market is witnessing a positive market growth owing to the factors such as rising prevalence of various cancers such as lung cancer which accounted for the highest number of cancer-related deaths and highest cancer incidence in 2022, and other indications such as cardiovascular diseases, and neurodegenerative diseases among others. Furthermore, the presence of factors such as growth in aging population wherein age plays a key role in the development of various indications is another factor driving the growth of the MIS devices market. Moreover, the technological advancements in product development such as the development of surgical robots is further driving the MIS devices market as new products are gaining regulatory approvals and are entering the market.

4. Who are the key players operating in Global MIS Devices Market?

Some of the key market players operating in the MIS devices market include Abbott, Olympus, Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, Boston Scientific Corporation, CONMED Corporation, KARL STORZ GmbH, CooperSurgical, Inc., Cook, AngioDynamics, FUJIFILM Corporation, Symmetry Surgical Inc, B. Braun Melsungen AG, BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Zimmer Biomet, Richard Wolf GmbH, Microport Scientific Corporation others.

5. Which region has the highest share in MIS Devices Market?

North America is expected to hold the highest share in the revenue in the MIS Devices market during the forecast period. Owing to significance of key growth factors such as rising growing prevalence of cancers, increasing prevalence of degenerative bone disorders, and rising government initiatives regarding disease treatment awareness, the North America MIS devices market is expected to register positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and high awareness also helped the market growth in this region.

Table of Contents

1.MIS Devices Market Report Introduction

2.MIS Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. MIS Devices Market Key Factors Analysis

• 4.1. MIS Devices Market Drivers
  • 4.1.1. Increasing Incidence of Various Diseases such as Cardiovascular Diseases and Cancers
  • 4.1.2. Growing Popularity of MIS Surgery
  • 4.1.3. Technological Advancements in Product Development
• 4.2. MIS Devices Market Restraints and Challenges
  • 4.2.1. Limited Availability of Skilled Professionals
  • 4.2.2. High Cost of MIS Devices
• 4.3. MIS Devices Market Opportunities
  • 4.3.1. Improving Affordability of MIS Devices
  • 4.3.2. Improving Skillset of Surgeons

5. MIS Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on MIS Devices Market

7. MIS Devices Market Layout

• 7.1. By Device Type
  • 7.1.1. Electrosurgical Devices
  • 7.1.2. Endoscopes
    • 7.1.2.1. Laparoscopes
    • 7.1.2.2. Neuroendoscopy Systems
    • 7.1.2.3. Others
  • 7.1.3. Inflation Devices
  • 7.1.4. Handheld Instruments
  • 7.1.5. Surgical Robotic Systems
  • 7.1.6. Others
• 7.2. By Application
  • 7.2.1. Cosmetic
  • 7.2.2. Orthopedic
  • 7.2.3. Neurological
  • 7.2.4. Gynecological
  • 7.2.5. Cardiovascular
  • 7.2.6. Others
• 7.3. By End User
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America MIS Devices Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe MIS Devices Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.2.6. Russia
    • 7.4.2.2.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific MIS Devices Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW MIS Devices Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. MIS Devices Market Global Company Share Analysis - Key 3-5 Companies

9. MIS Devices Market Company and Product Profiles

• 9.1. Abbott
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Olympus
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Intuitive Surgical Inc
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Stryker
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Medtronic
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Boston Scientific Corporation
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. CONMED Corporation
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. KARL STORZ GmbH
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. CooperSurgical Inc
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Cook
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. AngioDynamics
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. FUJIFILM Corporation
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Symmetry Surgical Inc
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. B. Braun Melsungen AG
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. BD
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Zimmer Biomet
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Richard Wolf GmbH
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Microport Scientific Corporation
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us